Literature DB >> 12604567

Enhanced in vitro activity of dihydrofolate reductase and dihydropteroase synthase inhibitors in combination against Nocardia spp.

Deborah M Thielking, Michelle S Destefano, Michael H Cynamon, Anthony E T Yeo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12604567      PMCID： PMC149340          DOI： 10.1128/AAC.47.3.1174.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  2 in total

1.  Phenoxypropoxybiguanides, prodrugs of DHFR-inhibiting diaminotriazine antimalarials.

Authors:  N P Jensen; A L Ager; R A Bliss; C J Canfield; B M Kotecka; K H Rieckmann; J Terpinski; D P Jacobus
Journal:  J Med Chem       Date:  2001-11-08       Impact factor: 7.446

2.  In vitro activities of PS-15, a new dihydrofolate reductase inhibitor, and its cyclic metabolite against Mycobacterium avium complex.

Authors:  S C Meyer; S K Majumder; M H Cynamon
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191
  2 in total
  1 in total

1.  In vitro activity of JPC 2067 alone and in combination with sulfamethoxazole against nocardia species.

Authors:  Swagatam Mookherjee; Carolyn Shoen; Michael Cynamon
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.